Emory Behavioral Immunology Program

We study interactions between the brain and the immune system, especially as they relate to the effects of inflammation on the development of psychiatric disorders including depression, anxiety disorders and schizophrenia. We also study the impact of inflammation on the brain in medically ill patients including patients with cancer. Special emphasis in our studies is placed on the effects of inflammation on neurotransmitter systems involving dopamine and glutamate as well as the integrity of local and regional brain networks. Finally, we are exploring a variety of treatment strategies that target the immune system to treat psychiatric disorders. By combining multiple frames of reference, we believe that novel approaches to human suffering can be achieved through strategies that address both brain and immune aspects of health and illness.

In The News

High Levels of Inflammation and Blood Glucose May Contribute to Anhedonia in MDD

A new paper from our group examines the combined presence of high blood glucose and low tyrosine metabolism in people with Major Depressive Disorder.

In The News

Can anti-inflammatory strategies light up the dim depression pipeline?

Several institutions and organizations including our own are advancing the research of anti-inflammatory drugs as treatment methods for depression and depressive symptoms. Read about it at Nature.

In The News

Microglia: a new target in the brain for depression, Alzheimer’s, and more?

Neuroinflammation is rapidly being tied to a number of physical and cognitive health issues, presenting a new direction for potential treatments.

In The News

Inflammation is Aging your Brain

Dr. Miller spoke with Dave Asprey on his Podcast, Bulletproof radio, to discuss inflammation's effects on aging. Listen to it here.

In The News

Science Says This Is How Stress Kills Your Motivation

How can you maintain your motivation during stressful times? Our research provides one answer. See more at Inc.

{"arrow":"true","pagination":"true","speed":"300","autoplay":"true","autoplay_speed":"3000","loop":"true","animation_flex":"slide","slide_to_show_flex":"8","max_slide_to_show_flex":"1","slide_to_scroll_flex":"1","slide_margin_flex":"0","slide_width_flex":"0","start_slide_flex":"0","ticker_hover_flex":"true","height_auto_flex":"false","random_start_flex":"false","caption":"false"}

Emory Behavioral Immunology ProgramFollow

Emory Behavioral Immunology Program @BIEmory·

12 May

New post: High Levels of Inflammation and Blood Glucose May Contribute to Anhedonia in MDD https://behavioralimmunology.com/?p=1977

Reply on Twitter 1260284617145253888 Retweet on Twitter 12602846171452538881 Like on Twitter 12602846171452538885

Emory Behavioral Immunology Program @BIEmory·

12 May

It is becoming more clear that inflammation alone is not enough to lead to anhedonia. Concomitant changes in metabolism may be required. Is the immune system communicating metabolic priorities? Check out this new paper and find out more https://www.psychiatryadvisor.com/home/depression-advisor/high-levels-of-inflammation-and-blood-glucose-may-contribute-to-anhedonia-in-mdd/?utm_source=newsletter&utm_medium=email&utm_campaign=pa-spotlight-hay-20200512&cpn=Psych_MD,latuda92069HL,latuda_bc,lat_ad,psych_all,latHCLL,lat_92069HCLL,lat_92069HCLLSEP,lat_92069HCLLNOV,abilify12518,latuda_nov2019&hmSubId=&hmEmail=n-IjzQa4Fs1NLS6jvphXkPPtfpnKDAau0&NID=1467555649&email_hash=54bf443e416ad7b5f1d27d24b3c70ef5&mpweb=1323-92056-1632543 @BIEmory

Reply on Twitter 1260209487383855104 Retweet on Twitter 12602094873838551042 Like on Twitter 12602094873838551045

Emory Behavioral Immunology Program @BIEmory·

5 Feb

Click the link to learn more. http://behavioralimmunology.com/get-involved-mdd/

Reply on Twitter 1225178258544693248 Retweet on Twitter 1225178258544693248 Like on Twitter 12251782585446932482